Law360, New York (February 21, 2008, 12:00 AM ET) -- After taking a closer look at the U.S. Supreme Court’s ruling in Riegel v. Medtronic, product liability lawyers are saying the decision is not as big of a victory for medical device makers as reported and is only going to preempt a small group of lawsuits.
In step with the majority of appeals court decisions, the Supreme Court determined 8-1 on Wednesday that companies whose medical devices have undergone a rigorous review process by the U.S. Food and Drug Administration cannot be sued under state law...
Scope Of Riegel V. Medtronic Is Narrow: Experts
To view the full article, take a free trial now.
